Redo afib ablation John R Onufer MD FHRS

Slides:



Advertisements
Similar presentations
AF ablation with 3D mapping: our technique and results
Advertisements

Atrial Fibrillation Ablation: My personal experience
Ali Alsayegh, MD, FRCPC,FACC Consultant Cardiologist, Consultant Cardiac Electrophysiologist.
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Atrial Fibrillation 2014 Christopher L. Fellows, MD, FACC, FHRS
Hybrid AF Ablation Sequential thoracoscopic and percutaneous ablation for Lone AF Dr Guy Haywood Consultant Cardiac Electrophysiologist South West Cardiothoracic.
How to do a Roof Line and Prove Block Dhiraj Gupta Liverpool Heart and Chest Hospital.
Ablation for Paroxysmal Atrial Fibrillation (APAF) Trial Presented at The American College of Cardiology Scientific Session 2006 Presented by Dr. Carlo.
INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION St. Mary’s Hospital February – August 2007.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Treating Atrial Fibrillation Richard Schilling St Bartholomew's Hospital, Queen Mary’s University of London.
John R Onufer MD FHRS.  Paroxysmal(that which terminates spontaneously) Persistent Sustained > 7 days, or lasting < 7 days but requires pharmacologic.
Audit of ablation procedures for AF Barts and The London.
Late outcomes of the Cox-Maze IV procedure for atrial fibrillation Matthew C. Henn MD, Timothy S. Lancaster MD, Jacob R. Miller MD, Laurie A. Sinn RN,
Catheter Ablation of Atrial Fibrillation in the Elderly
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation What is New in the 2006 ACC/AHA/ESC Guidelines HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation. May 2007.
Basic Mechanisms of Atrial Fibrillation Relative to Ablation Osama Diab MD, Cardiology Lecturer of Cardiology, Ain Shams Universitry-Cairo Consultant Electrophysiologist,
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial by Atul Verma, Roberto Mantovan,
Catheter Ablation of Atrial Fibrillation: Who? How? How Good? John D. Day, M.D. Director, Utah Cardiovascular Research Institute Utah Heart Clinic Arrhythmia.
AF: Catheter Ablation Isolation of the 4 pulmonary veins Linear lesions to create additional lines of block 1.
Catheter Ablation of AF Electrogram-based Approach
Asklepios Klink St. Georg, Hamburg
COMMON CARDIAC ARRHYTHMIAS 2 the complex arrhythmias Mark Earley, St Bartholomew’s Hospital.
SWEDMAF Trial Presented at The Heart Rhythm Society Meeting May 2006 Presented by Dr. Carina Blomstrom-Lundqvist SWEDMAF Trial.
Catheter Ablation of Atrial Fibrillation in the Last 10 Years: Breakthroughs and Advances Dr. Feifan Ouyang Asklepios Klinik St. Georg Hamburg Sept. 19th,
Donghui Yang, Lianjun Gao Department of Cardiology First affiliated hospital of Dalian Medical University Will the endpoint of AF ablation be unified?
A-4 Trial Presented at The Heart Rhythm Society Meeting May 2006 Presented by Dr. Pierre Jais Atrial Fibrillation Ablation vs. Antiarrhythmic Drugs Trial.
Catheter Ablation of AF Electrogram-based Approach Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei,
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Atrial fibrillation April 2010 : 1,980,000 March 2011: 2,550,000 hits November 2014: 9,500,000 hits.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: New Magnetic Resonance Imaging-Based Method for.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for the Management of.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Catheter-induced linear lesions in theleft atrium.
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comparison of Radiofrequency Catheter Ablation of.
Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial.
Atrial tachycardia originating from the right superior pulmonary vein (RSPV) after sinus node crushing and SG stimulation. Atrial tachycardia originating.
Fontan Global Case Conference Richard J. Czosek, MD 6/28/17
Left atrial ablation for atrial fibrillation. A
Video-assisted minimally invasive surgery for lone atrial fibrillation: A clinical report of 81 cases  Yong-qiang Cui, MD, PhD, Yan Li, MD, Feng Gao,
Surgical treatment of atrial fibrillation: State of the art, 2012
Reentrant and Focal Activations During Atrial Fibrillation in Patients With Atrial Septal Defect  Takashi Nitta, MD, PhD, Shun-ichiro Sakamoto, MD, PhD,
Κολπικη μαρμαρυγη σε ασθενεις με αποφρακτικη υπνικη απνοια
Circ Arrhythm Electrophysiol
James L. Cox, MD  The Journal of Thoracic and Cardiovascular Surgery 
Circ Arrhythm Electrophysiol
Circ Arrhythm Electrophysiol
Where does atrial fibrillation surgery fail
AF ablation with 3D mapping: our technique and results
(p for noninferiority = )
Video-assisted minimally invasive surgery for lone atrial fibrillation: A clinical report of 81 cases  Yong-qiang Cui, MD, PhD, Yan Li, MD, Feng Gao,
MAGIC-AF Trial design: Patients with persistent atrial fibrillation (AF) and remaining in AF after pulmonary vein isolation alone were randomized to either.
Initial Experience of Sequential Surgical Epicardial-Catheter Endocardial Ablation for Persistent and Long-Standing Persistent Atrial Fibrillation With.
Catheter Ablation for the Cure of Atrial Fibrillation Study
Junaid A.B. Zaman et al. JACEP 2017;3:
Recurrent Atrial Arrhythmia After Minimally Invasive Pulmonary Vein Isolation for Atrial Fibrillation  Yaping Zeng, MD, Yongqiang Cui, MD, Yan Li, MD,
ΝΟΣΟΣ ΤΑΧΥΒΡΑΔΥΚΑΡΔΙΑΣ: ΕΜΦΥΤΕΥΣΗ ΒΗΜΑΤΟΔΟΤΗ Η ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ ; ΓΕΩΡΓΙΟΣ ΣΤΑΥΡΟΠΟΥΛΟΣ ΕΠ.Α ΚΑΡΔΙΟΛΟΓΟΣ ΓΝΘ ΙΠΠΟΚΡΑΤΕΙΟ.
AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top.
Junaid A.B. Zaman et al. JACEP 2017;3:
Patients with Advanced Fibrotic Myopathy Should be Surgically Ablated
Risk Factor Modification
Stavros Stavrakis et al. JACEP 2015;1:1-13
Restoration of sinus rhythm and atrial transport function after the maze procedure: U lesion set versus box lesion set  Takashi Nitta, MD, PhD, Yosuke.
Correlation between functional electrical gaps identified by ultrahigh-density mapping and by late gadolinium enhancement cardiac magnetic resonance in.
Atrial fibrillation I: a new classification system
Borut Geršak, MD, PhD, Matevž Jan, MD  The Annals of Thoracic Surgery 
Left Atrial Fibrosis Assessed with Cardiac MRI in Patients with Paroxysmal and Those with Persistent Atrial Fibrillation More than two left atrial segments.
NICE 2014 Check pulse in patients presenting with:
Constantine Mavroudis, MD, Carl L. Backer, MD, Barbara J
Presentation transcript:

Redo afib ablation John R Onufer MD FHRS Best approach is to achieve complete durable pv isolation the first time

Why we fail at atrial fib ablations Repeated ablations 1. Lesions not permanent 2. More ablation targets 3. Mechanism ?

Primary Effectiveness Analysis Treatment Success 30 days CRYO 69.9% 114/163 Treatment success (%) P<0.001 DRUG Rx 7.3% 6/82 Blanked Days KM estimate 68.6% (SE 3.9%) vs 7.3% (SE 2.9%)

Five year single center results 1. One procedure, successful rate is low 2. Results could be better if all patients agreed to have multiple procedures

When does Recurrence Occur Early (<3 months) Marker of increased risk of long term failure However, 30-50% go on to be free of afib long term Late (3-12 months) More likely to represent Rx failure Early recurrence and multiple AF foci during original procedure strongest predictors of late recurrence. Very late (>12 months) Majority will have pv reconnection and have other non pulmonary sites ablated.

Surgical Maze procedure Freedom from symptomatic AF at 10 years was 85%. Circ Arrhythm Electrophysiol 2012;5;8-14

Recurrent Atrial arrhythmias after afib ablation PV reconnection Non-PV triggers Focal or re-entrant atrial tachycardias Aflutter Tv-ivc isthmus La mitral annulus La septal or roof

Frequency of arrhythmias at time of repeat ablation Reconnected PV >95% PV trigger 54-77% Development of new trigger 14-18% Stable, regular arrhythmia other than afib 18.7-50% La Flutter 6.7% Ra Flutter 6.7% Mainigi: JCEP 2007

Risk Factors for recurrence Type and duration of afib Proxysmal vs persistent Cardiac structural abnormalities LA size, LV function, HCM Characteristic of the atrial electrical substrate Clinical factors Htn, osa, increased BMI

PV recurrence Mechanism likely multifactorial Inadequate PV isolation Inadequate recognition and treatment of preexisting non pv substrate Under detection of earlier recurrences Interval disease progression despite sinus rhythm (atrial remodeling and fibrosis)

Redo Atrial fibrillation Ablation Stop-AF: proxysmal afib redo rate 20% Thermacool afib: Paroxysmal and persistent afib redo rate 12% TTOP: Long lasting persistent afib redo rate (not yet published)

Detecting and modifying PV reconnnection Waiting time Adenosine Steroids Atntiarrhythmic drugs Upstream therapy

Waiting time 75 pts with paf mean age 55 Double lasso, pv venography and /or 3D mapping The 4 PVs were individually targeted Waiting time 30, 60, 90 min Yamanee,et al. Circ AE 2011,4:601-608

The demonstration of the mean number of reconnection gaps at each provocation step (A, right superior and right inferior pulmonary vein [PV]; B, left superior and left inferior PV). The demonstration of the mean number of reconnection gaps at each provocation step (A, right superior and right inferior pulmonary vein [PV]; B, left superior and left inferior PV). As shown in A, the mean number of reconnected gaps was largest in time 1 and decreased according to the progression of provocative stage in the right superior PV (•), whereas no significant difference was observed among the provocative stages in the right inferior PV (○). B, Similar to the right veins, the mean number of reconnected gaps decreased according to the progression of provocative stage in the left superior PV (♦), whereas no significant difference was observed among the stages in the left inferior PV (◊). In both the right and left superior PVs, the number of reconnected gaps was significantly smaller at ATP 1, time 3, and ATP 3 compared with that of time 1 (*P<0.01). Yamane T et al. Circ Arrhythm Electrophysiol 2011;4:601-608 Copyright © American Heart Association

HRS concensus document 1. Ablation strategies that target the PVs and or the PV antrum are the cornerstone for most AF procedures If the PVs are targeted, electrical isolation should be the goal Achievement of electrical isolation requires, at a minimum, assessment and demonstration of entrance block into the PV. Monitoring for PV reconduction for 20 minutes following initial PV isolation should be considered.

Practical Approach to Redo Procedures PVs isolated yes no Isolate PVs SVC, CS, Ligament Of Marshal, Crista Terimalis, LA posterior wall Ablate non-PV triggers Ablate inducible atrial flutters Anatomical Non-PV Ablation

Implications Better characterization of of non PV baseline substrate Pt counseling and education Improved efforts to identify mechanism at time or reablation

Thank you